New research in neurofeedback is showing promise for those with autism, ADHD, Parkinson’s disease, and chronic pain conditions like fibromyalgia. Can it help those with environmental intolerances, too?
Ashok Gupta has announced the publication of the Clinical Audit Study this month on Gupta Amygdala Retraining™ treatments for ME/CFS, Fibromyalgia and MCS.
Help save people at risk of homelessness who are currently receiving Section 8 Housing Choice Vouchers. Make a phone call before Thursday, July 1st in support of funding for this program.
The creator of the Dynamic Neural Retraining System™ talks face-to-face with the author of The Brain That Changes Itself about chemical intolerance and the promise of a brain plasticity treatment approach.
Submit your writing and art for an anthology articulating the terrain of trauma and resilience – a collaboration of the Icarus Project, the Bay Area Radical Mental Health Collective, and Activist Trauma Support.
The Mayo Clinic is conducting a pilot study of the Gupta Amygdala Retraining™ Programme for patients with chronic fatigue syndrome (CFS) and fibromyalgia (FMS).
MCS America’s article “Preying on the Desperate: Miracle Cures Hold False Promise” by Lourdes Salvador and Linda Sepp is full of disinformation.
Salvador López Arnal interviews Eva Caballé, Spanish author and MCS activist, about her new book “Desaparecida. Una vida rota por la sensibilidad química múltiple” (“Missing. A life broken by Multiple Chemical Sensitivities”).
Planet Thrive founder Julie Genser interviews Ashok Gupta to get a more in-depth view into the Amygdala Retraining™ Program for CFS/ME and related disorders.
Fibromyalgia drug Lyrica and its former less potent version Neurontin have both been shown to “block the formation of new brain synapses, drastically reducing the potential for rejuvenating brain plasticity.”
